DENNIS HEANEY: Open Payments
NPI 1437868254 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,755 in 221 payments from 20 companies in 2025. Trend: 2023 $4,212 · 2024 $3,738 · 2025 $3,755
Food & beverage: $3,755
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $431 |
| Axsome Therapeutics, Inc. | 26 | $427 |
| Neurocrine BioSciences, Inc. | 27 | $356 |
| ABBVIE INC. | 28 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $289 |
| Noven Therapeutics, LLC | 23 | $284 |
| Alkermes, Inc. | 19 | $283 |
| Otsuka America Pharmaceutical, Inc. | 19 | $253 |
| Vanda Pharmaceuticals Inc. | 12 | $241 |
| Janssen Pharmaceuticals, Inc | 7 | $221 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, Auvelity, TRINTELLIX, Xelstrym, REXULTI, FANAPT.
Industry payments across OK — which companies pay providers there.
